218 related articles for article (PubMed ID: 25387952)
21. Novel homozygous mutation, c.400C>T (p.Arg134*), in the PVRL1 gene underlies cleft lip/palate-ectodermal dysplasia syndrome in an Asian patient.
Yoshida K; Hayashi R; Fujita H; Kubota M; Kondo M; Shimomura Y; Niizeki H
J Dermatol; 2015 Jul; 42(7):715-9. PubMed ID: 25913853
[TBL] [Abstract][Full Text] [Related]
22. A chromatin immunoprecipitation screen in mouse keratinocytes reveals Runx1 as a direct transcriptional target of DeltaNp63.
Ortt K; Raveh E; Gat U; Sinha S
J Cell Biochem; 2008 Jul; 104(4):1204-19. PubMed ID: 18275068
[TBL] [Abstract][Full Text] [Related]
23. p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes.
Qu J; Yi G; Zhou H
Epigenetics Chromatin; 2019 Jun; 12(1):31. PubMed ID: 31164150
[TBL] [Abstract][Full Text] [Related]
24. Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.
Chung J; Grant RI; Kaplan DR; Irwin MS
J Biol Chem; 2011 Nov; 286(47):40671-80. PubMed ID: 21965674
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC).
Rinne T; Bolat E; Meijer R; Scheffer H; van Bokhoven H
Am J Med Genet A; 2009 Sep; 149A(9):1948-51. PubMed ID: 19676060
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects.
Lo Iacono N; Mantero S; Chiarelli A; Garcia E; Mills AA; Morasso MI; Costanzo A; Levi G; Guerrini L; Merlo GR
Development; 2008 Apr; 135(7):1377-88. PubMed ID: 18326838
[TBL] [Abstract][Full Text] [Related]
27. Nectinopathies: an emerging group of ectodermal dysplasia syndromes.
Brancati F; Agolini E; Fortugno P
G Ital Dermatol Venereol; 2013 Feb; 148(1):59-64. PubMed ID: 23407077
[TBL] [Abstract][Full Text] [Related]
28. Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome.
Brancati F; Fortugno P; Bottillo I; Lopez M; Josselin E; Boudghene-Stambouli O; Agolini E; Bernardini L; Bellacchio E; Iannicelli M; Rossi A; Dib-Lachachi A; Stuppia L; Palka G; Mundlos S; Stricker S; Kornak U; Zambruno G; Dallapiccola B
Am J Hum Genet; 2010 Aug; 87(2):265-73. PubMed ID: 20691405
[TBL] [Abstract][Full Text] [Related]
29. ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.
Romano RA; Smalley K; Magraw C; Serna VA; Kurita T; Raghavan S; Sinha S
Development; 2012 Feb; 139(4):772-82. PubMed ID: 22274697
[TBL] [Abstract][Full Text] [Related]
30. p63 Transcription Factor Regulates Nuclear Shape and Expression of Nuclear Envelope-Associated Genes in Epidermal Keratinocytes.
Rapisarda V; Malashchuk I; Asamaowei IE; Poterlowicz K; Fessing MY; Sharov AA; Karakesisoglou I; Botchkarev VA; Mardaryev A
J Invest Dermatol; 2017 Oct; 137(10):2157-2167. PubMed ID: 28595999
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of loricrin expression by cell adhesion molecule nectin-1 through Rap1-ERK signaling in keratinocytes.
Wakamatsu K; Ogita H; Okabe N; Irie K; Tanaka-Okamoto M; Ishizaki H; Ishida-Yamamoto A; Iizuka H; Miyoshi J; Takai Y
J Biol Chem; 2007 Jun; 282(25):18173-18181. PubMed ID: 17472964
[TBL] [Abstract][Full Text] [Related]
32. Mutant p63 Affects Epidermal Cell Identity through Rewiring the Enhancer Landscape.
Qu J; Tanis SEJ; Smits JPH; Kouwenhoven EN; Oti M; van den Bogaard EH; Logie C; Stunnenberg HG; van Bokhoven H; Mulder KW; Zhou H
Cell Rep; 2018 Dec; 25(12):3490-3503.e4. PubMed ID: 30566872
[TBL] [Abstract][Full Text] [Related]
33. A novel p63 sterile alpha motif (SAM) domain mutation in a Japanese patient with ankyloblepharon, ectodermal defects and cleft lip and palate (AEC) syndrome without ankyloblepharon.
Tsutsui K; Asai Y; Fujimoto A; Yamamoto M; Kubo M; Hatta N
Br J Dermatol; 2003 Aug; 149(2):395-9. PubMed ID: 12932250
[TBL] [Abstract][Full Text] [Related]
34. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
Westfall MD; Mays DJ; Sniezek JC; Pietenpol JA
Mol Cell Biol; 2003 Apr; 23(7):2264-76. PubMed ID: 12640112
[TBL] [Abstract][Full Text] [Related]
35. The p63 target HBP1 is required for skin differentiation and stratification.
Borrelli S; Candi E; Hu B; Dolfini D; Ravo M; Grober OM; Weisz A; Dotto GP; Melino G; Viganò MA; Mantovani R
Cell Death Differ; 2010 Dec; 17(12):1896-907. PubMed ID: 20523354
[TBL] [Abstract][Full Text] [Related]
36. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
McGrath JA; Duijf PH; Doetsch V; Irvine AD; de Waal R; Vanmolkot KR; Wessagowit V; Kelly A; Atherton DJ; Griffiths WA; Orlow SJ; van Haeringen A; Ausems MG; Yang A; McKeon F; Bamshad MA; Brunner HG; Hamel BC; van Bokhoven H
Hum Mol Genet; 2001 Feb; 10(3):221-9. PubMed ID: 11159940
[TBL] [Abstract][Full Text] [Related]
37. Isoform-Specific Roles of Mutant p63 in Human Diseases.
Osterburg C; Osterburg S; Zhou H; Missero C; Dötsch V
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33572532
[TBL] [Abstract][Full Text] [Related]
38. Master regulatory role of p63 in epidermal development and disease.
Soares E; Zhou H
Cell Mol Life Sci; 2018 Apr; 75(7):1179-1190. PubMed ID: 29103147
[TBL] [Abstract][Full Text] [Related]
39. p63 directly induces expression of Alox12, a regulator of epidermal barrier formation.
Kim S; Choi IF; Quante JR; Zhang L; Roop DR; Koster MI
Exp Dermatol; 2009 Dec; 18(12):1016-21. PubMed ID: 19555433
[TBL] [Abstract][Full Text] [Related]
40. p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis.
Fessing MY; Mardaryev AN; Gdula MR; Sharov AA; Sharova TY; Rapisarda V; Gordon KB; Smorodchenko AD; Poterlowicz K; Ferone G; Kohwi Y; Missero C; Kohwi-Shigematsu T; Botchkarev VA
J Cell Biol; 2011 Sep; 194(6):825-39. PubMed ID: 21930775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
